Dispersyn Gerrit 4
4 · Phio Pharmaceuticals Corp. · Filed Mar 3, 2022
Insider Transaction Report
Form 4
Dispersyn Gerrit
Chief Development Officer
Transactions
- Tax Payment
Common stock, $0.0001 par value
2022-03-01$0.82/sh−8,954$7,351→ 212,327 total
Footnotes (2)
- [F1]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold.
- [F2]Includes shares of common stock underlying unvested restricted stock units.